Literature DB >> 8595421

CAG repeat expansions and schizophrenia: association with disease in females and with early age-at-onset.

A G Morris1, E Gaitonde, P J McKenna, J D Mollon, D M Hunt.   

Abstract

An increase in the severity of schizophrenia through consecutive generations (anticipation) has been found in some studies of families with affected members. Anticipation in five neurological disorders is known to arise from the expansion of CAG repeats between generations of affected individuals. The 'repeat expansion detection' method was used to screen individual genomes for the size of such expansions in a sample of schizophrenic and normal subjects. Comparison of the frequency distribution of CAG expansions observed in schizophrenic patients to that for normal subjects, showed that there are significantly more expansions in patients (p = 0.048). When male and female subjects are considered separately, there is a highly significant difference in the distribution of repeat sizes found between affected and normal females (p = 0.0023) but no significant difference between affected and normal males. Overall there is a 28% excess of expansions observed in affected versus normal females, and their presence confers a relative risk of 4.12 (p < 0.005). In contrast, the frequency distribution of age-at-onset with respect to repeat size is nearly the same in male and female patients and, when the sexes are combined, the larger (CAG)69-136 expansions are associated with a younger age-at-onset (p = 0.02).

Entities:  

Mesh:

Year:  1995        PMID: 8595421     DOI: 10.1093/hmg/4.10.1957

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

Review 1.  Genetics of schizophrenia and the new millennium: progress and pitfalls.

Authors:  M Baron
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

Review 2.  Paternal factors and schizophrenia risk: de novo mutations and imprinting.

Authors:  D Malaspina
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

3.  Anticipation or ascertainment bias in schizophrenia? Penrose's familial mental illness sample.

Authors:  A S Bassett; J Husted
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

4.  Exclusion of CAG repeat expansion as the cause of disease in autosomal dominant retinitis pigmentosa families.

Authors:  T J Keen; A G Morris; C F Inglehearn
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 5.  The role of candidate genes in the etiology of schizophrenia.

Authors:  K C Murphy; P McGuffin
Journal:  Mol Med       Date:  1996-11       Impact factor: 6.354

6.  Reproductive fitness in familial schizophrenia.

Authors:  A S Bassett; A Bury; K A Hodgkinson; W G Honer
Journal:  Schizophr Res       Date:  1996-09-18       Impact factor: 4.939

7.  An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus.

Authors:  J B Vincent; M L Neves-Pereira; A D Paterson; E Yamamoto; S V Parikh; F Macciardi; H M Gurling; S G Potkin; C N Pato; A Macedo; M Kovacs; M Davies; J A Lieberman; H Y Meltzer; A Petronis; J L Kennedy
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 8.  Molecular genetics of schizophrenia: past, present and future.

Authors:  Suman Prasad; Prachi Semwal; Smita Deshpande; Triptish Bhatia; V L Nimgaonkar; B K Thelma
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

9.  Uncloned expanded CAG/CTG repeat sequences in autosomal dominant cerebellar ataxia (ADCA) detected by the repeat expansion detection (RED) method.

Authors:  M A Pujana; V Volpini; M Gratacós; J Corral; I Banchs; A Sánchez; D Genís; C Cervera; X Estivill
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

10.  Multivariate analysis of factors influencing repeat expansion detection.

Authors:  C Zander; J Thelaus; K Lindblad; M Karlsson; K Sjöberg; M Schalling
Journal:  Genome Res       Date:  1998-10       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.